Current perspectives with pemetrexed in thoracic malignancies

Research output: Contribution to journalEditorial

Original languageEnglish (US)
JournalClinical Lung Cancer
Volume5
Issue numberSUPPL. 2
DOIs
StatePublished - Jan 1 2004

Fingerprint

Pemetrexed
Thorax
Neoplasms

All Science Journal Classification (ASJC) codes

  • Oncology
  • Pulmonary and Respiratory Medicine
  • Cancer Research

Cite this

@article{15fac4c13c034ddcb93690ad3eaece39,
title = "Current perspectives with pemetrexed in thoracic malignancies",
author = "Chandra Belani",
year = "2004",
month = "1",
day = "1",
doi = "10.3816/CLC.2004.s.001",
language = "English (US)",
volume = "5",
journal = "Clinical Lung Cancer",
issn = "1525-7304",
publisher = "Elsevier",
number = "SUPPL. 2",

}

Current perspectives with pemetrexed in thoracic malignancies. / Belani, Chandra.

In: Clinical Lung Cancer, Vol. 5, No. SUPPL. 2, 01.01.2004.

Research output: Contribution to journalEditorial

TY - JOUR

T1 - Current perspectives with pemetrexed in thoracic malignancies

AU - Belani, Chandra

PY - 2004/1/1

Y1 - 2004/1/1

UR - http://www.scopus.com/inward/record.url?scp=2342658476&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=2342658476&partnerID=8YFLogxK

U2 - 10.3816/CLC.2004.s.001

DO - 10.3816/CLC.2004.s.001

M3 - Editorial

AN - SCOPUS:2342658476

VL - 5

JO - Clinical Lung Cancer

JF - Clinical Lung Cancer

SN - 1525-7304

IS - SUPPL. 2

ER -